JP2010505795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505795A5 JP2010505795A5 JP2009530876A JP2009530876A JP2010505795A5 JP 2010505795 A5 JP2010505795 A5 JP 2010505795A5 JP 2009530876 A JP2009530876 A JP 2009530876A JP 2009530876 A JP2009530876 A JP 2009530876A JP 2010505795 A5 JP2010505795 A5 JP 2010505795A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- chlamydia trachomatis
- pmpdpd
- momp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 30
- 230000002163 immunogen Effects 0.000 claims 26
- 241000606153 Chlamydia trachomatis Species 0.000 claims 18
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 18
- 239000012634 fragment Substances 0.000 claims 12
- 102000040430 polynucleotide Human genes 0.000 claims 9
- 108091033319 polynucleotide Proteins 0.000 claims 9
- 239000002157 polynucleotide Substances 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 239000002671 adjuvant Substances 0.000 claims 4
- 241000606161 Chlamydia Species 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 208000001860 Eye Infections Diseases 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000011323 eye infectious disease Diseases 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000007764 o/w emulsion Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 210000004392 genitalia Anatomy 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82809206P | 2006-10-04 | 2006-10-04 | |
| PCT/EP2007/060500 WO2008040757A1 (en) | 2006-10-04 | 2007-10-03 | Vaccines against chlamydial infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505795A JP2010505795A (ja) | 2010-02-25 |
| JP2010505795A5 true JP2010505795A5 (enExample) | 2010-11-25 |
Family
ID=39092594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009530876A Pending JP2010505795A (ja) | 2006-10-04 | 2007-10-03 | クラミジア感染症に対するワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100172927A1 (enExample) |
| EP (1) | EP2068916A1 (enExample) |
| JP (1) | JP2010505795A (enExample) |
| KR (1) | KR20090077065A (enExample) |
| CN (1) | CN101522215A (enExample) |
| AU (1) | AU2007304199A1 (enExample) |
| BR (1) | BRPI0719169A2 (enExample) |
| CA (1) | CA2664236A1 (enExample) |
| EA (1) | EA200900338A1 (enExample) |
| MX (1) | MX2009003127A (enExample) |
| WO (1) | WO2008040757A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20080213264A1 (en) * | 1998-12-08 | 2008-09-04 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US8541007B2 (en) | 2005-03-31 | 2013-09-24 | Glaxosmithkline Biologicals S.A. | Vaccines against chlamydial infection |
| US9259463B2 (en) * | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| US8735543B2 (en) | 2010-05-28 | 2014-05-27 | Spixia Biotechnology Ab | Chimeric MOMP antigen |
| EP3220962A4 (en) | 2014-11-21 | 2018-07-25 | Merck Sharp & Dohme Corp. | Recombinant expression of chlamydia momp antigen |
| CN104800841B (zh) * | 2015-03-02 | 2019-04-02 | 中国农业科学院兰州兽医研究所 | 牦牛流产衣原体灭活疫苗及其制备方法 |
| CN111735967B (zh) * | 2020-08-03 | 2020-12-22 | 天津中逸安健生物科技有限公司 | 一种重组新型冠状病毒疫苗吸附完全性检测方法 |
| AR132053A1 (es) | 2023-03-02 | 2025-05-21 | Sanofi Pasteur | Composiciones para su uso en el tratamiento de clamidia |
| WO2025076210A1 (en) * | 2023-10-03 | 2025-04-10 | Vaxcyte, Inc. | Chlamydia vaccine compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2277892A3 (en) * | 1998-12-08 | 2011-04-27 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20020146776A1 (en) * | 2000-04-21 | 2002-10-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20030199438A1 (en) * | 2001-04-09 | 2003-10-23 | Shaw Allan Christian | Method for identification of proteins from intracellular bacteria |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
| ES2312649T3 (es) * | 2001-12-12 | 2009-03-01 | Novartis Vaccines And Diagnostics S.R.L. | Inmunizacion frente a chlamydia trachomatis. |
| WO2005027961A2 (en) * | 2003-09-23 | 2005-03-31 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Chlamydia pmpd autotransporter and its role as adhesin |
| US7892567B2 (en) * | 2007-10-01 | 2011-02-22 | Board Of Regents, The University Of Texas System | Methods and compositions for immunization against chlamydial infection and disease |
-
2007
- 2007-10-03 AU AU2007304199A patent/AU2007304199A1/en not_active Abandoned
- 2007-10-03 EP EP07820877A patent/EP2068916A1/en not_active Withdrawn
- 2007-10-03 CN CNA2007800373166A patent/CN101522215A/zh active Pending
- 2007-10-03 KR KR1020097009229A patent/KR20090077065A/ko not_active Withdrawn
- 2007-10-03 MX MX2009003127A patent/MX2009003127A/es not_active Application Discontinuation
- 2007-10-03 WO PCT/EP2007/060500 patent/WO2008040757A1/en not_active Ceased
- 2007-10-03 BR BRPI0719169-3A patent/BRPI0719169A2/pt not_active IP Right Cessation
- 2007-10-03 JP JP2009530876A patent/JP2010505795A/ja active Pending
- 2007-10-03 CA CA002664236A patent/CA2664236A1/en not_active Abandoned
- 2007-10-03 US US12/442,538 patent/US20100172927A1/en not_active Abandoned
- 2007-10-03 EA EA200900338A patent/EA200900338A1/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505795A5 (enExample) | ||
| JP2008534594A5 (enExample) | ||
| UA97943C2 (ru) | Вакцина против инфекции chlamydia | |
| EA200900338A1 (ru) | Вакцины против хламидийной инфекции | |
| JP2016040284A5 (enExample) | ||
| JP2007538044A5 (enExample) | ||
| EP2181714A3 (en) | Immunogenic composition for use in vaccination against staphylococcei | |
| EP2255826A3 (en) | Neisserial vaccine compositions comprising a combination of antigens | |
| WO2008054540A3 (en) | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | |
| JP2013502918A5 (enExample) | ||
| WO2006031825A3 (en) | Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof | |
| CL2013002106A1 (es) | Composicion inmunogenica de streptococcus pneumoniae que comprende 2 o mas conjugados de sacarido capsular de diferentes serotipos; vacuna que la comprende; procedimiento de fabricacion; y su uso para tratar o prevenir enfermedades causadas por la infeccion por streptococcus pneumoniae (div.sol.n°3625-2006). | |
| WO2008020335A8 (en) | Immunogenic compositions for streptococcus agalactiae | |
| JP2016502551A5 (enExample) | ||
| JP2009520758A5 (enExample) | ||
| WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
| WO2005122741A3 (en) | Antibodies against west nile virus and therapeutic and prophylactic uses thereof | |
| JP2016522259A5 (enExample) | ||
| WO2005028618A3 (en) | Immunogenic compositions for streptococcus agalactiae | |
| JP2015529677A5 (enExample) | ||
| BR0208367B1 (pt) | Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina | |
| WO2001078774A3 (en) | Recombinant intracellular pathogen vaccines and methods for use | |
| WO2008153772A3 (en) | Chlamydia vaccine comprising htra polypeptides | |
| EP2270171A3 (en) | Haemophilus influenzae antigens and corresponding DNA fragments | |
| WO2009071613A3 (en) | Vaccine |